SLPI and osteoarthritis: Secretory Leukocyte Protease Inhibitor (SLPI) has emerged as a multifaceted modulator in osteoarthritis (OA), acting through anti-inflammatory, anti-protease, chondroprotective, and immunomodulatory pathways (Figure 2).